未登录

J

Jason Lohmueller

university of pittsburgh

H指数:16

被引数:5,017

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Programmable apoptosis circuits enable subtractive engineering of stem cell-derived organoids and embryoids

可编程凋亡电路实现干细胞衍生的类器官和类胚的减法工程

IF20.4

2026-10-220

PRE

AMPK enhances CART function through increased oxidative capacity and improved control of cellular ROS

JOURNAL OF IMMUNOLOGY

IF3.4

2025-11-010

PRE

Small-molecule control of CAR T cells

小分子对CAR T细胞的调控

Nature Reviews Chemistry

IF51.7

2025-10-290

PRE

Conditional Control of Benzylguanine Reaction with the Self-Labeling SNAP-tag Protein

自标记SNAP-tag蛋白对苄基鸟嘌呤反应的条件控制

BIOCONJUGATE CHEMISTRY

IF3.9

2025-02-200

OAAI

Preventative Cancer Vaccine-Elicited Human Anti-MUC1 Antibodies Have Multiple Effector Functions

IF2.7

2024-10-100

OAAI

CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under the control of antigen sensing in microwell arrays

在微孔阵列中抗原传感的控制下，3D乳腺癌球体核心内的CAR T细胞浸润和细胞毒性杀伤

APL BIOENGINEERING

IF4.1

2024-07-231

OAAI

Conditional Control of Universal CAR T Cells by Cleavable OFF-Switch Adaptors

可切割开关适配器对通用CAR T细胞的条件控制

ACS SYNTHETIC BIOLOGY

IF3.9

2023-10-048

OAAI

Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting

用于可编程抗原靶向的CAR和synNotch受体的翻译后共价组装

NATURE COMMUNICATIONS

IF15.7

2023-05-0927

OAAI

Generation and validation of anti-linker monoclonal antibodies for the detection of surface expressed scFv-based

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2023-03-1333

OAAI

Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology

完全鼠CD105-targeted car-t细胞为car-t细胞生物学提供免疫活性模型

IF6.3

2022-10-184

OA

Pre-assembled universal SNAP-CARs show potent anti-tumor function

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

PRE

The costimulatory activity of Tim-3 requires Akt and MAPK signaling and its recruitment to the immune synapse

SCIENCE SIGNALING

IF6.6

2021-06-1532

OA

Special issue: Immune cells in the tumor microenvironment

CELLULAR IMMUNOLOGY

IF2.9

2019-09-010

PREAI

TCRβ repertoire analysis from a prophylactic MUC1 cancer vaccine trial

CANCER RESEARCH

IF16.6

2018-07-010

PRE

mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting

IF6.3

2017-10-26114

OAAI

Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines

PHARMACOLOGY & THERAPEUTICS

IF12.5

2017-10-0175

OAAI

msa2 biotin-binding CAR combined with biotinylated tumor-specific antibodies or DNA aptamers for universal cancer immunotherapy

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential

SCIENTIFIC REPORTS

IF3.9

2016-08-2236

OAAI

Human anti-MUC1 antibodies elicited by a prophylactic cancer vaccine for mAb and CAR-modified T cell immunotherapies

CANCER RESEARCH

IF16.6

2015-08-010

PRE